Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Nov;44(11):2133-2146.
doi: 10.1002/jum.16756. Epub 2025 Jun 30.

The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes

Affiliations
Case Reports

The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes

Roni Yoeli-Bik et al. J Ultrasound Med. 2025 Nov.

Abstract

Borderline ovarian tumors, which are of epithelial origin, exhibit malignant histological features without stromal invasion. They differ from invasive ovarian carcinomas since often diagnosed in younger patients, at an early stage, and have a more favorable prognosis. This allows a more conservative surgical approach for some patients who desire fertility‐sparing surgeries. Grayscale, color and power Doppler ultrasonography are the initial imaging modalities for characterizing adnexal masses and evaluating their risk of malignancy. This review summarizes the main sonographic features of borderline ovarian tumors that are useful for pattern recognition.

Keywords: borderline tumor; ovarian epithelial carcinoma; ovarian neoplasm; ultrasound.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serous ovarian tumors. Serous borderline ovarian tumors usually appear on ultrasonography Doppler imaging as cystic lesions with numerous vascularized papillary projections (A–F). Rarely, however, they may show an exophytic growth pattern with predominantly solid tumors that exhibit rich hierarchical vascular branching (i.e., a fireworks sign; G). Serous low‐grade ovarian cancer (H, I) often presents as irregular solid lesions with exophytic growth (H) or cystic lesions with endophytic papillary projections (I). Hyperechoic foci representing small calcifications may also be present (yellow arrows in I).
Figure 2
Figure 2
Mucinous borderline ovarian tumors. Mucinous borderline ovarian tumors are mostly unilateral, large multilocular cystic lesions containing more than 10 locules (A–D) with scattered low‐level echogenicity. Honeycomb nodules may be present (E–H). Rarely, a solid component may be visualized (yellow star in H).
Figure 3
Figure 3
Pseudomyxoma peritonei. Pseudomyxoma peritonei often appears as echogenic ascites with diffused septations (green arrows in A and red triangles in B) and centrally displaced fixed bowels (yellow star in B).
Figure 4
Figure 4
Seromucinous borderline ovarian tumors and differential diagnosis. Seromucinous borderline ovarian tumors are often cystic lesions with numerous vascularized papillary projections and ground‐glass cyst echogenicity, reflecting their association with endometriosis (A–D). Notably, in the differential diagnosis, atypical endometrioma may present as a cystic lesion with ground‐glass cyst echogenicity and papillary projections; however, it usually does not show vascular flow on Doppler imaging (E). In contrast, decidualized endometriomas during pregnancy may also contain papillary projections that are almost always highly vascularized on Doppler imaging (F).
Figure 5
Figure 5
Rare borderline ovarian tumors. Clear cell and endometrioid BOTs are predominantly large solid tumors with small to large cystic areas on macroscopic examinations. Indeed, both the clear cell (A) and endometrioid (B) BOT cases showed large solid components with cystic areas and high vascular flow on Doppler imaging. Brenner BOTs macroscopic appearance is often described as cystic lesions with papillary projections. In this case (C), a cystic lesion with what appears to be a large papillary projection is present.
Figure 6
Figure 6
Borderline ovarian tumors and microcystic pattern. Ultrasonography microcystic pattern on grayscale (top row) and 3D‐silhouette mode (bottom row) in serous borderline (A), seromucinous borderline (B), and mucinous borderline ovarian tumors (C).
Figure 7
Figure 7
Differential diagnosis of borderline tumors with microcystic pattern. Ultrasonography grayscale (top row) and 3D‐silhouette mode (bottom row) of ovarian tumors presenting the microcystic pattern (white arrows) in benign cystadenofibroma (A), benign struma ovarii (B), and malignant invasive endometrioid carcinoma (C).
Figure 8
Figure 8
Example of microvascular imaging presenting extremely small, thin blood vessels of the size of arterioles in a borderline ovarian tumor using a 9–5 MHz transvaginal ultrasound transducer set to a pulse repetition frequency of 0.18 kHz.
Figure 9
Figure 9
Ultrasound imaging of serous borderline ovarian tumor using radiant color Doppler US (CDUS) with a PRF of 0.6 kHz and microvascular imaging (MVI) using a PRF of 0.21 kHz. Note the difference in the details of the vascular patterns.
Figure 10
Figure 10
Ultrasound imaging of mucinous borderline ovarian tumor by radiant color Doppler US (CDUS) using a PRF of 0.6 kHz and microvascular imaging (MVI) using a PRF of 0.21 kHz. Note the difference in the details of the vascular patterns.

References

    1. Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet 2021; 155:61–85. 10.1002/ijgo.13878. - DOI - PMC - PubMed
    1. du Bois A, Ewald‐Riegler N, de Gregorio N, et al. Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer 2013; 49:1905–1914. 10.1016/j.ejca.2013.01.035. - DOI - PubMed
    1. Fischerova D, Zikan M, Dundr P, Cibula D. Diagnosis, treatment, and follow‐up of borderline ovarian tumors. Oncologist 2012; 17:1515–1533. 10.1634/theoncologist.2012-0139. - DOI - PMC - PubMed
    1. Song T, Lee YY, Choi CH, et al. Histologic distribution of borderline ovarian tumors worldwide: a systematic review. J Gynecol Oncol 2013; 24:44–51. 10.3802/jgo.2013.24.1.44. - DOI - PMC - PubMed
    1. Schuurman MS, Timmermans M, van Gorp T, et al. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis. Acta Oncol 2019; 58:983–989. 10.1080/0284186X.2019.1619935. - DOI - PubMed

Publication types

LinkOut - more resources